---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-120067"
form_type: "8-K"
ticker: "INMB"
cik: "0001711754"
company_name: "Inmune Bio, Inc."
filed_at: "2025-12-10T23:59:59+00:00"
generated_at: "2026-05-16T13:39:05.643920+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# INmune Bio terminates $75M ATM sales agreement with RBC and BTIG effective Dec 19, 2025

## Summary
- Company notified RBC and BTIG of termination on Dec 5 and Dec 9, 2025; effective Dec 19.
- No termination penalties or expenses incurred.
- Prior to termination, co. raised ~$10.5M net proceeds through sale of 1,353,469 shares.
- Original agreement allowed up to $75M in at-the-market offerings since Aug 2024.

## SEC filing metadata
- accession: 0001213900-25-120067
- form_type: 8-K
- ticker: INMB
- cik: 0001711754
- company_name: Inmune Bio, Inc.
- filed_at: 2025-12-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711754/000121390025120067/0001213900-25-120067-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711754/000121390025120067/ea0269071-8k_inmune.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-120067
- JSON: https://secwatch.observer/filing/0001213900-25-120067.json
- Plain text: https://secwatch.observer/filing/0001213900-25-120067.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.